Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Procollagen C-endopeptidase enhancer 1 (PCOLCE) is a secreted glycoprotein that binds the C-terminal propeptide of type I procollagen, enhancing its enzymatic removal by procollagen C-proteinases (such as BMP-1), thereby promoting maturation and assembly of fibrillar collagen in the extracellular matrix. PCOLCE participates in extracellular matrix remodeling, impacts immune cell migration and signaling, and plays a role in multiple pathological conditions including cancer, fibrosis, and defective tissue repair. It is highly expressed in certain tumor types and correlates with poor clinical prognosis and chemotherapy sensitivity. Its biological functions extend to regulation of immune responses and modulation of the tumor microenvironment.
Targeting upstream or downstream signaling of collagen processing, ECM remodeling, or immune modulation Influencing sensitivity to chemotherapy by altering the tumor microenvironment and immune cell infiltration
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Procollagen C-endopeptidase enhancer 1 (PCOLCE).